C12N 2760/18462
By genetic engineering
Official title: by genetic engineering
C12N2760/18462 (By genetic engineering) appears on 8 US grants and 10 published applications in this corpus.
Search patents in C12N- Granted patents
- 8
- Published applications
- 10
- Assignees
- 17
- Inventors
- 12
- Latest grant
- 17 Sep 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 1 | 1 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 1 | 3 |
| 2019 | 1 | 0 |
| 2020 | 2 | 2 |
| 2021 | 1 | 0 |
| 2022 | 1 | 0 |
| 2023 | 0 | 1 |
| 2024 | 1 | 0 |
By publication year.
Recent patents
- Modulation of replicative fitness by deoptimization of synonymous codons17 Sep 2024US 12,090,197 B2The Government of the USA, as represented by the Secretary, Department of Health and Human Services
- Modulation of replicative fitness by deoptimization of synonymous codons15 Nov 2022US 11,497,803 B2The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention
- Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (MV-deltaC virus) in cancer therapy20 Apr 2021US 10,980,873 B2Centre National de la Recherche Scientifique (CNRS)
- Tunable vaccine platform against pathogens of the paramyxovirus family22 Sep 2020US 10,780,158 B2Georgia State University Research Foundation, Inc.
- Modulation of replicative fitness by deoptimization of synonymous codons30 Jun 2020US 10,695,414 B2The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services, Center for Disease Control and Prevention
- Modulation of replicative fitness by deoptimization of synonymous codons31 Aug 2023US 2023/0270833 A1The Government of the U.S.A. as represented by the Secretary of the Dept. of Health & Human Services
- Modulation of replicative fitness by deoptimization of synonymous codons27 Aug 2020US 2020/0268865 A1The Government of the U.S.A. as represented by the Secretary of the Dept. of Health & Human Services
- Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (mv-deltac virus) in cancer therapy16 Jan 2020US 2020/0016260 A1Centre National De La Recherche Scientifique
- Tunable vaccine platform against pathogens of the paramyxovirus family15 Nov 2018US 2018/0326046 A1Georgia State University Reseach Foundation, Inc.
- Modulation of replicative fitness by deoptimization of synonymous codons20 Sep 2018US 2018/0264098 A1The Government of the USA as represented by the Secretary of the Dept. of Health and Human Service
Most cited
By later US patents
- Modulation of replicative fitness by deoptimization of synonymous codons20US 8,846,051 B2The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · 2014
- Modulation of replicative fitness by deoptimization of synonymous codons4US 10,695,414 B2The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services, Center for Disease Control and Prevention · 2020
- Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (MV-deltaC virus) in cancer therapy2US 9,889,193 B2Centre National De La Recherche Scentifique (Cnrs) · 2018
- Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (MV-deltaC virus) in cancer therapy1US 10,314,905 B2Centre National De La Recherche Scentifique (Cnrs) · 2019